Chiusura precedente | 104,50 |
Aperto | 104,80 |
Denaro | 104,30 x 0 |
Lettera | 104,60 x 0 |
Min-Max giorno | 103,90 - 104,80 |
Intervallo di 52 settimane | 89,55 - 145,66 |
Volume | |
Media Volume | 1.577.078 |
Capitalizzazione | 770,487M |
Beta (5 anni mensile) | 1,62 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -21,30 |
Prossima data utili | 12 giu 2023 - 16 giu 2023 |
Rendimento e dividendo (forward) | 0,02 (1,78%) |
Data ex dividendo | 17 nov 2022 |
Stima target 1A | 133,75 |
Novo Nordisk – major shareholder announcement Bagsværd, Denmark, 6 May 2022 – Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) that Blackrock as of 29 April 2022 holds B shares equal to 5.06% of the entire share capital of Novo Nordisk. The announcement is in accordance with section 30 of the Danish Capital Markets Act. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 3
Bagsværd, Denmark, 6 May 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated person